A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

The FDA approved the first drug in its class that targets moderate to severe acute pain in adults, without being addictive ...

One of the most frequent questions that my organization Ematai receives relates to administering pain medications toward the end of life. For many conscious patients who are dying from a terminal ...

The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...

Paul Howe, chief commercial officer at Protega, discusses efforts to combine high tech solutions with pain-management medications. The opioid crisis in the United States continues to cause chaos and ...

(CNN) — The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram ...

Mefenamic acid, a common anti-inflammatory drug already approved for pain management ... who are exposed to very small doses of this medication. Mefenamic acid is already available in a generic ...

This bipartisan legislation would ensure that Medicare covers non-opioid pain medications, giving seniors access to safer treatment options without facing higher costs or hoops to jump through.

(NEW YORK) — The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called ...

Journavx, a new non-opioid pain medication, offers a safer alternative for managing acute pain while reducing the risk of addiction.